Analytic Investors’s Bristol-Myers Squibb BMY Stock Holding History

Analytic Investors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$100M	Buy	1,861,534 +362,268	+24%	+$23.3M	1.12%	22
2016 Q2	$110M	Buy	1,499,266 +245,961	+20%	+$17.4M	1.3%	18
2016 Q1	$80.1M	Buy	1,253,305 +656,906	+110%	+$41.4M	0.98%	25
2015 Q4	$41M	Buy	596,399 +279,751	+88%	+$18.5M	0.51%	52
2015 Q3	$18.7M	Sell	316,648 -1,485	-0.5%	-$94.2K	0.25%	96
2015 Q2	$21.2M	Buy	318,133 +310,041	+3,831%	+$20.4M	0.3%	84
2015 Q1	$522K	Sell	8,092 -9,725	-55%	-$609K	0.01%	441
2014 Q4	$1.05M	Buy	+17,817	New	+$1M	0.01%	347
2013 Q4	–	Sell	-5,079	Closed	-$235K	–	506
2013 Q3	$235K	Buy	+5,079	New	+$223K	﹤0.01%	469

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Analytic Investors's BMY Position: Q3 2016 in Review

Analytic Investors increased its Bristol-Myers Squibb (BMY) stake by 24% in Q3 2016, buying an estimated $23.3M and bringing the position to 1,861,534 shares worth $100M. The position accounts for 1.12% of the portfolio, ranked #22.

Analytic Investors first reported a position in BMY in Q3 2013 and has held it in 9 quarters since. The position peaked at $110M in Q2 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Analytic Investors held 1,861,534 shares of Bristol-Myers Squibb worth $100M as of Q3 2016.
Analytic Investors bought 362,268 Bristol-Myers Squibb shares in Q3 2016, an estimated $23.3M.
Bristol-Myers Squibb made up 1.12% of Analytic Investors's portfolio in Q3 2016, its #22 holding.
Analytic Investors first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 9 quarters since.
Analytic Investors's Bristol-Myers Squibb position peaked at $110M in Q2 2016.
1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.